Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | JSPR | CRVS | ||
| Company | Revance Therapeutics | Jasper Therapeutics Inc. | Corvus Pharma Com | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.07 | 21.12 | 5.02 | ||
| High | 3.09 | 22.20 | 5.34 | ||
| Low | 3.07 | 21.00 | 4.73 | ||
| Last | 3.09 | 21.57 | 4.99 | ||
| Change | +0.02 | +0.04 | -0.10 | ||
| % Change | +0.65% | +0.19% | -1.96% | ||
| Volume | 3,458,700 | 212,500 | 2,585,800 | ||
| 20-Day Average Volume | 3,648,075 | 181,830 | 1,642,340 | ||
| Previous Close | 3.07 | 21.53 | 5.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.46 | 22.22 | 7.74 | ||
| 20-Day Raw Stochastic | 6.67% | 32.53% | 21.11% | ||
| 20-Day Relative Strength | 35.03% | 49.75% | 32.75% | ||
| Weighted Alpha | -72.19 | +66.55 | +158.97 | ||
| Today's Opinion | 80% Sell | 32% Buy | 24% Buy | ||
| Previous Opinion | 56% Sell | 32% Buy | 24% Buy | ||
| Last Month's Opinion | 24% Sell | 24% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.32% since 12/13/24 | +4.71% since 12/13/24 | -32.38% since 12/13/24 | ||
| Low | 3.06 on 12/17/24 | 19.41 on 12/16/24 | 3.77 on 12/18/24 | ||
| High | 3.09 on 12/19/24 | 23.11 on 12/17/24 | 7.44 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -18.68% since 11/20/24 | +2.81% since 11/20/24 | -39.44% since 11/20/24 | ||
| Low | 3.01 on 12/09/24 | 19.41 on 12/16/24 | 3.77 on 12/18/24 | ||
| High | 4.21 on 11/27/24 | 26.05 on 12/03/24 | 9.55 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | -46.82% since 09/20/24 | -9.67% since 09/20/24 | -15.57% since 09/20/24 | ||
| Low | 3.01 on 12/09/24 | 14.42 on 10/10/24 | 3.77 on 12/18/24 | ||
| High | 6.09 on 10/28/24 | 26.05 on 12/03/24 | 10.00 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +7.67% since 06/20/24 | -1.33% since 06/20/24 | +161.26% since 06/20/24 | ||
| Low | 2.30 on 06/26/24 | 14.42 on 10/10/24 | 1.75 on 07/05/24 | ||
| High | 6.65 on 08/19/24 | 26.05 on 12/03/24 | 10.00 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 322,565 | 323,572 | 320,642 | ||
| Shares Outstanding, K | 104,390 | 15,001 | 64,257 | ||
| Annual Sales | 234,040,000 | 0 | 0 | ||
| Annual Net Income | -323,990,000 | -64,470,000 | -27,030,000 | ||
| Last Quarter Sales | 59,880,000 | 0 | 0 | ||
| Last Quarter Net Income | -38,120,000 | -18,640,000 | -40,220,000 | ||
| 60-Month Beta | 0.81 | 2.18 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | -1.24 on 11/07/24 | -0.11 on 11/12/24 | ||
| Latest Earnings Date | 11/13/24 | 11/14/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||